SEMAGLUTIDE
FDA-approved for weight management as Wegovy since June 2021
FDA-approved for type 2 diabetes as Ozempic since 2017
Semaglutide is an FDA-approved injectable prescription medication used for weight management in adults. It works by mimicking the action of a naturally occurring hormone in the body called GLP-1 (glucagon- like peptide-1). This hormone helps regulate blood sugar levels and appetite. When semaglutide is administered, it stimulates the release of insulin, reduces the production of glucagon, and slows down the emptying of the stomach. These actions collectively contribute to weight loss by promoting a feeling of fullness, reducing food intake, and improving insulin sensitivity.
TIRZEPATIDE
FDA-approved for weight management as Zepbound since Nov 2023
FDA-approved for type 2 diabetes as Mounjaro since May 2022
Tirzepatide works by mimicking the GLP-1 and GIP hormones that are naturally secreted by the intestine after a meal, which prompts insulin secretion. It also reduces appetite by slowing down the time it takes the stomach to empty and interacting with areas in the brain harboring GLP-1 receptors to signal satiety.
RETATRUTIDE
Completed phase 2 clinical studies in 2023
Currently in phase 3 clinical studies (expected to conclude 2026)
FDA-approval anticipated 2027
Retatrutide is an experimental drug for obesity. It has finished phase II clinical studies and currently in phase III clinical studies. It works by mimicking three hormones in the gut, and in turn, controls glucose levels, decreases appetite, and increases feeling of fullness. It may be more effective in preserving lean muscle than its predecessors.
How it works
THE 4 EASY STEPS
INFORMATION
Weight loss injections operate by replicating the actions of natural hormones responsible for regulating appetite and blood sugar levels. This leads to reduced feelings of hunger and increased sensations of fullness. The journey toward weight loss with these injections initiates with a comprehensive telemedicine/email consultation with the doctor.
PRICE
$249 for first patient consultation (includes 3 months of program services)
Month 4+: $59/month
Medication costs are not included above. Email us for the most recent medication price list (subject to change by individual pharmacy).
Semaglutide: as low as $125 for the first 8 weeks
Tirzepatide: as low as $230 for the first 8 weeks
THE RESULTS
Upon achieving the optimal dosage, the focus shifts to maintaining the attained weight loss and supporting overall health enhancements. Consistent administration of injections becomes integral, accompanied by lifestyle adjustments to sustain the benefits.
ONGOING SUPPORT
In your weight loss journey, support is not just a one-time occurrence; it’s an ongoing commitment to your success. We are dedicated to providing continuous support and guidance every step of the way. Whether you have questions, need encouragement, or require adjustments to your treatment plan, we are here for you.